UAB Comprehensive Diabetes Center (UCDC) members and trainees will share their latest scientific findings at the world’s largest diabetes conference, the American Diabetes Association (ADA) 85th Scientific Sessions, June 20-23, at the McCormick Place Convention Center in Chicago.
Last year’s meeting in Orlando featured more than 200 sessions and 2,000 original research presentations, according to the ADA. This year, UCDC faculty and trainees will showcase their work in a variety of symposiums, oral presentations, and poster presentations throughout the conference.
See the list of presentations below.
UCDC at ADA
Symposiums
Ashley Battarbee, M.D., MSCR, “Controversies in Peripartum Management of Diabetes”
W. Timothy (Tim) Garvey, M.D., MACE, “Efficacy and Safety of CagriSema 2.4mg/2.4mg in Adults with Overweight/Obesity—The REDEFINE 1 and REDEFINE 2 Clinical Trials”
Carrie R Howell, Ph.D., “Preventing Risk Factors for Type 2 Diabetes—Primordial Prevention of Type 2 Diabetes”
Oral Presentations
Haifa Alsharif, Ph.D., postdoctoral scholar, Bhatnagar Lab, “Brain-Angiogenesis Inhibitor-3 Ablation Enhances Brown Adipose Tissue Thermogenesis and Protects against Obesity”
Alaaeldin Hodhod, M.D., endocrine postdoctoral fellow, Basu Lab, “Effects of Dorzagliatin, Insulin Glargine, and Metformin on Nocturnal Endogenous Glucose Production in Type 2 Diabetes”
Uma S. Unni, Ph.D., postdoctoral scholar, Basu Lab, “Mixed Meals Containing Complex Carbohydrates Improves Insulin Sensitivity and Disposition Index in Type 2 Diabetes—Mechanistic Insights Using Minimal Model Analyses”
Poster Presentations
Sushant Bhatnagar, Ph.D., “Tomosyn-2 Regulates Beta-Cell Proliferation and Insulin Secretion in Neonatal Islets”
Fernando Bril, M.D, “Liver Fibrosis Predicts Mortality in Type 2 Diabetes (T2D) Independently of Obesity and A1C”
SeongHo Jo, Ph.D., Shalev Lab, “Treating Glucose Intolerance and High-Fat Diet–Induced Adiposity with the Novel Antidiabetic TIX100”
Teayoun Kim, Ph.D., Habbeger Lab, “Multiomic Analyses of GLP-1/GIP/GCGR Triagonism Highlights the Role of Hepatic Lipid Metabolism during Weight Loss in Obese Mice” and “Bile Acid Binding Resins Improve Glucagon Receptor Agonist-Mediated Weight Loss in Diet-Induced Obese Mice”
Brian Lu, Ph.D., Shalev Lab, “Cluster Analysis Reveals Increased Proportion of Patients with Severe Diabetes Subtypes following the COVID-19 Pandemic”
Uma S. Unni, Ph.D., postdoctoral scholar, Basu Lab, “Dorzagliatin Increases Hepatic UDP Glucose Flux via the Direct Pathway in Type 2 Diabetes—New Glucokinase Activator for Type 2 Diabetes?”
Guanlan Xu, Ph.D., Shalev Lab, “Verapamil Inhibits Vascular Adhesion Molecules in Pancreatic Islets”
Marian L. Yurchishin, MS, nutrition sciences pre-doctoral training fellow, Gower Lab, “Ketogenic Diet-Induced Depletion of Hepatic Fat Is Associated with Restored Beta-Cell Function Independent of Weight Loss”
If you have an upcoming ADA, ENDO 2025, or other conference presentation you would like to share, email